Literature DB >> 27798624

Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality.

Ruben N Eppinga1, Yanick Hagemeijer1, Stephen Burgess2, David A Hinds3, Kari Stefansson4,5, Daniel F Gudbjartsson4,6, Dirk J van Veldhuisen1, Patricia B Munroe7,8, Niek Verweij1, Pim van der Harst1,9,10.   

Abstract

Resting heart rate is a heritable trait correlated with life span. Little is known about the genetic contribution to resting heart rate and its relationship with mortality. We performed a genome-wide association discovery and replication analysis starting with 19.9 million genetic variants and studying up to 265,046 individuals to identify 64 loci associated with resting heart rate (P < 5 × 10-8); 46 of these were novel. We then used the genetic variants identified to study the association between resting heart rate and all-cause mortality. We observed that a genetically predicted resting heart rate increase of 5 beats per minute was associated with a 20% increase in mortality risk (hazard ratio 1.20, 95% confidence interval 1.11-1.28, P = 8.20 × 10-7) translating to a reduction in life expectancy of 2.9 years for males and 2.6 years for females. Our findings provide evidence for shared genetic predictors of resting heart rate and all-cause mortality.

Entities:  

Mesh:

Year:  2016        PMID: 27798624     DOI: 10.1038/ng.3708

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  36 in total

1.  The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

Authors:  E Kristal-Boneh; H Silber; G Harari; P Froom
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

Review 2.  Rest heart rate and life expectancy.

Authors:  H J Levine
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.

Authors:  Ariel Diaz; Martial G Bourassa; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  Eur Heart J       Date:  2005-03-17       Impact factor: 29.983

4.  Heart rate and mortality.

Authors:  A Reunanen; J Karjalainen; P Ristola; M Heliövaara; P Knekt; A Aromaa
Journal:  J Intern Med       Date:  2000-02       Impact factor: 8.989

5.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

6.  Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study.

Authors:  Xiongjing Jiang; Xiaoxue Liu; Shouling Wu; Gus Q Zhang; Meng Peng; Yuntao Wu; Xiaoming Zheng; Chunyu Ruan; Weiguo Zhang
Journal:  Heart       Date:  2014-09-01       Impact factor: 5.994

7.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study.

Authors:  R F Gillum; D M Makuc; J J Feldman
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

8.  Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Authors:  F H Messerli; E Grossman; U Goldbourt
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

9.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set.

Authors:  Masahiro Kanai; Toshihiro Tanaka; Yukinori Okada
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

View more
  55 in total

1.  Heritability of resting heart rate and association with mortality in middle-aged and elderly twins.

Authors:  Magnus T Jensen; Mette Wod; Søren Galatius; Jacob B Hjelmborg; Gorm B Jensen; Kaare Christensen
Journal:  Heart       Date:  2017-06-21       Impact factor: 5.994

2.  Mortality selection in a genetic sample and implications for association studies.

Authors:  Benjamin W Domingue; Daniel W Belsky; Amal Harrati; Dalton Conley; David R Weir; Jason D Boardman
Journal:  Int J Epidemiol       Date:  2017-08-01       Impact factor: 7.196

3.  Phenotype-Specific Enrichment of Mendelian Disorder Genes near GWAS Regions across 62 Complex Traits.

Authors:  Malika Kumar Freund; Kathryn S Burch; Huwenbo Shi; Nicholas Mancuso; Gleb Kichaev; Kristina M Garske; David Z Pan; Zong Miao; Karen L Mohlke; Markku Laakso; Päivi Pajukanta; Bogdan Pasaniuc; Valerie A Arboleda
Journal:  Am J Hum Genet       Date:  2018-10-04       Impact factor: 11.025

4.  Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study.

Authors:  Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Queen N Aghaji; Bharath Ambale-Venkatesh; Jamal S Rana; Norrina B Allen; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima
Journal:  Am J Med       Date:  2020-01-27       Impact factor: 4.965

Review 5.  Genomics of Cardiovascular Measures of Autonomic Tone.

Authors:  Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

6.  Enhancer Domains Predict Gene Pathogenicity and Inform Gene Discovery in Complex Disease.

Authors:  Xinchen Wang; David B Goldstein
Journal:  Am J Hum Genet       Date:  2020-02-06       Impact factor: 11.025

7.  β2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.

Authors:  Mohamed H Shahin; Nihal El Rouby; Daniela J Conrado; Daniel Gonzalez; Yan Gong; Maximilian T Lobmeyer; Amber L Beitelshees; Eric Boerwinkle; John G Gums; Arlene Chapman; Stephen T Turner; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Clin Pharmacol       Date:  2019-05-14       Impact factor: 3.126

8.  Epigenomic and Transcriptomic Dynamics During Human Heart Organogenesis.

Authors:  Jennifer VanOudenhove; Tara N Yankee; Andrea Wilderman; Justin Cotney
Journal:  Circ Res       Date:  2020-08-09       Impact factor: 17.367

Review 9.  How Heart Rate Should Be Controlled in Patients with Atherosclerosis and Heart Failure.

Authors:  Rose Mary Ferreira Lisboa da Silva; Anaisa Silva Roever Borges; Nilson Penha Silva; Elmiro Santos Resende; Gary Tse; Tong Liu; Leonardo Roever; Giuseppe Biondi-Zoccai
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

10.  Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits.

Authors:  Aldi T Kraja; Chunyu Liu; Jessica L Fetterman; Mariaelisa Graff; Christian Theil Have; Charles Gu; Lisa R Yanek; Mary F Feitosa; Dan E Arking; Daniel I Chasman; Kristin Young; Symen Ligthart; W David Hill; Stefan Weiss; Jian'an Luan; Franco Giulianini; Ruifang Li-Gao; Fernando P Hartwig; Shiow J Lin; Lihua Wang; Tom G Richardson; Jie Yao; Eliana P Fernandez; Mohsen Ghanbari; Mary K Wojczynski; Wen-Jane Lee; Maria Argos; Sebastian M Armasu; Ruteja A Barve; Kathleen A Ryan; Ping An; Thomas J Baranski; Suzette J Bielinski; Donald W Bowden; Ulrich Broeckel; Kaare Christensen; Audrey Y Chu; Janie Corley; Simon R Cox; Andre G Uitterlinden; Fernando Rivadeneira; Cheryl D Cropp; E Warwick Daw; Diana van Heemst; Lisa de Las Fuentes; He Gao; Ioanna Tzoulaki; Tarunveer S Ahluwalia; Renée de Mutsert; Leslie S Emery; A Mesut Erzurumluoglu; James A Perry; Mao Fu; Nita G Forouhi; Zhenglong Gu; Yang Hai; Sarah E Harris; Gibran Hemani; Steven C Hunt; Marguerite R Irvin; Anna E Jonsson; Anne E Justice; Nicola D Kerrison; Nicholas B Larson; Keng-Hung Lin; Latisha D Love-Gregory; Rasika A Mathias; Joseph H Lee; Matthias Nauck; Raymond Noordam; Ken K Ong; James Pankow; Amit Patki; Alison Pattie; Astrid Petersmann; Qibin Qi; Rasmus Ribel-Madsen; Rebecca Rohde; Kevin Sandow; Theresia M Schnurr; Tamar Sofer; John M Starr; Adele M Taylor; Alexander Teumer; Nicholas J Timpson; Hugoline G de Haan; Yujie Wang; Peter E Weeke; Christine Williams; Hongsheng Wu; Wei Yang; Donglin Zeng; Daniel R Witte; Bruce S Weir; Nicholas J Wareham; Henrik Vestergaard; Stephen T Turner; Christian Torp-Pedersen; Evie Stergiakouli; Wayne Huey-Herng Sheu; Frits R Rosendaal; M Arfan Ikram; Oscar H Franco; Paul M Ridker; Thomas T Perls; Oluf Pedersen; Ellen A Nohr; Anne B Newman; Allan Linneberg; Claudia Langenberg; Tuomas O Kilpeläinen; Sharon L R Kardia; Marit E Jørgensen; Torben Jørgensen; Thorkild I A Sørensen; Georg Homuth; Torben Hansen; Mark O Goodarzi; Ian J Deary; Cramer Christensen; Yii-Der Ida Chen; Aravinda Chakravarti; Ivan Brandslund; Klaus Bonnelykke; Kent D Taylor; James G Wilson; Santiago Rodriguez; Gail Davies; Bernardo L Horta; Bharat Thyagarajan; D C Rao; Niels Grarup; Victor G Davila-Roman; Gavin Hudson; Xiuqing Guo; Donna K Arnett; Caroline Hayward; Dhananjay Vaidya; Dennis O Mook-Kanamori; Hemant K Tiwari; Daniel Levy; Ruth J F Loos; Abbas Dehghan; Paul Elliott; Afshan N Malik; Robert A Scott; Diane M Becker; Mariza de Andrade; Michael A Province; James B Meigs; Jerome I Rotter; Kari E North
Journal:  Am J Hum Genet       Date:  2018-12-27       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.